South Korea · Delayed Price · Currency is KRW SD Biosensor Statistics
Total Valuation
SD Biosensor has a market cap or net worth of KRW 848.13 billion. The enterprise value is 670.42 billion.
| Market Cap | 848.13B |
| Enterprise Value | 670.42B |
Important Dates
The last earnings date was Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
SD Biosensor has 118.62 million shares outstanding. The number of shares has decreased by -1.60% in one year.
| Current Share Class | 118.62M |
| Shares Outstanding | 118.62M |
| Shares Change (YoY) | -1.60% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 32.91% |
| Owned by Institutions (%) | 2.59% |
| Float | 30.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | 2.69 |
| P/OCF Ratio | 2.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.38, with an EV/FCF ratio of 2.13.
| EV / Earnings | n/a |
| EV / Sales | 0.93 |
| EV / EBITDA | 18.38 |
| EV / EBIT | n/a |
| EV / FCF | 2.13 |
Financial Position
The company has a current ratio of 5.07, with a Debt / Equity ratio of 0.13.
| Current Ratio | 5.07 |
| Quick Ratio | 3.37 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 6.45 |
| Debt / FCF | 0.99 |
| Interest Coverage | -0.81 |
Financial Efficiency
Return on equity (ROE) is -17.98% and return on invested capital (ROIC) is -3.70%.
| Return on Equity (ROE) | -17.98% |
| Return on Assets (ROA) | -1.51% |
| Return on Invested Capital (ROIC) | -3.70% |
| Return on Capital Employed (ROCE) | -2.97% |
| Weighted Average Cost of Capital (WACC) | 12.79% |
| Revenue Per Employee | 1.25B |
| Profits Per Employee | -817.23M |
| Employee Count | 576 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 1.63 |
Taxes
| Income Tax | -403.09B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.02% in the last 52 weeks. The beta is 0.69, so SD Biosensor's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -38.02% |
| 50-Day Moving Average | 7,977.40 |
| 200-Day Moving Average | 8,937.60 |
| Relative Strength Index (RSI) | 38.40 |
| Average Volume (20 Days) | 160,246 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SD Biosensor had revenue of KRW 718.78 billion and -470.73 billion in losses. Loss per share was -3,935.13.
| Revenue | 718.78B |
| Gross Profit | 328.28B |
| Operating Income | -81.81B |
| Pretax Income | -875.35B |
| Net Income | -470.73B |
| EBITDA | 48.66B |
| EBIT | -81.81B |
| Loss Per Share | -3,935.13 |
Balance Sheet
The company has 497.60 billion in cash and 313.63 billion in debt, with a net cash position of 183.98 billion or 1,550.97 per share.
| Cash & Cash Equivalents | 497.60B |
| Total Debt | 313.63B |
| Net Cash | 183.98B |
| Net Cash Per Share | 1,550.97 |
| Equity (Book Value) | 2.37T |
| Book Value Per Share | 19,793.38 |
| Working Capital | 770.95B |
Cash Flow
In the last 12 months, operating cash flow was 370.08 billion and capital expenditures -54.64 billion, giving a free cash flow of 315.45 billion.
| Operating Cash Flow | 370.08B |
| Capital Expenditures | -54.64B |
| Depreciation & Amortization | 130.46B |
| Net Borrowing | -385.42B |
| Free Cash Flow | 315.45B |
| FCF Per Share | 2,659.32 |
Margins
Gross margin is 45.67%, with operating and profit margins of -11.38% and -65.49%.
| Gross Margin | 45.67% |
| Operating Margin | -11.38% |
| Pretax Margin | -121.78% |
| Profit Margin | -65.49% |
| EBITDA Margin | 6.77% |
| EBIT Margin | -11.38% |
| FCF Margin | 43.89% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 2.80%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 2.80% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.60% |
| Shareholder Yield | 4.41% |
| Earnings Yield | -55.50% |
| FCF Yield | 37.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SD Biosensor has an Altman Z-Score of 2.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.32 |
| Piotroski F-Score | 5 |